No Data
No Data
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Despite Selling Recently, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Insiders Own 38% Stake and Recent Decline Might Have Cost Them
RBC Capital Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $13
Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)
Verrica Pharmaceuticals Is Maintained at Buy by Needham
Verrica Pharmaceuticals Analyst Ratings
No Data